Press Releases

Get the latest on BIO's announcements, positions and views on everything from healthcare to biofuels. 

Featured Press Releases
Virginia Governor Glenn Youngkin named BIO’s…
WASHINGTON, DC (September 17, 2024) – Today, the Biotechnology Innovation Organization (BIO) awarded Virginia Governor Glenn Youngkin with its 2024 Governor of the Year Award. BIO’s annual award honors governors for their leadership and…
New Season of “I am BIO” Podcast Explores Patient…
WASHINGTON - (September 5, 2024) –The Biotechnology Innovation Organization (BIO) will launch the fall season of the award-winning “I am BIO” podcast on September 10. Now entering its fifth year, the podcast explores the intersection of…
BIO Statement On Selected Drugs in Medicare under…
The Biotechnology Innovation Organization (BIO) released the following statement after today’s announcement from the Centers for Medicare & Medicaid Services (CMS) on selected drugs under the Inflation Reduction Act (IRA):“While the Inflation…
All Press Releases
  • Show All
Search
Results
Event Tags
February 8, 2018
The steady decline of America as an innovation-supporting economy is due to an unbalanced patent challenge system.  
February 5, 2018
Washington, D.C. (February 5, 2018) – The following statement may be attributed to BIO President & CEO James Greenwood:“I congratulate Andrei Iancu on his Senate confirmation to fill the position of Under Secretary of Commerce for Intellectual…
January 30, 2018
Washington, D.C. (January 30, 2018) – The Biotechnology Innovation Organization (BIO) is applauding a new agreement announced by the U.S. Department of Agriculture (USDA) and the Food and Drug Administration (FDA) to enhance coordination between the…
January 24, 2018
BIO Congratulates Alex Azar on Confirmation asSecretary of Health and Human Services Washington, DC (January 24, 2018) – Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood issued the following statement regarding…
January 18, 2018
First-of-its-kind report highlights the need to stimulate development efforts for depression therapeutics. Washington, DC (January 18, 2018) – Today, the Biotechnology Innovation Organization (BIO) released a new report, The State of…
January 10, 2018
Washington, DC (January 10, 2018) – BIO President and CEO Jim Greenwood issued the following statement regarding the review of the 340B drug pricing program released by the House Energy & Commerce Committee today:
January 9, 2018
“Biotechnology Sector is a Driver of the ‘Fourth Industrial Revolution’”Washington, D.C. (January 9, 2018) – The Biotechnology Innovation Organization (BIO) is applauding a new report from the Interagency Task Force on Agriculture and Rural…
January 2, 2018
Washington, DC (January 2, 2018) – “BIO joins the nation – and the great state of Utah – in applauding Senator Hatch for his many years of service, and for proving time and time again to be a strong champion for biomedical innovation."
December 21, 2017
Washington, DC (December 21, 2017) – Today, the Biotechnology Innovation Organization (BIO) applauds the House of Representatives for passing H.R. 4015, the Corporate Governance Reform and Transparency Act.  This bipartisan bill, sponsored…
December 14, 2017
U.S. Government and 16 like-minded WTO Members Call forImplementation of the Sanitary and Phytosanitary (SPS) AgreementWashington, D.C. (December 14, 2017) – The Biotechnology Innovation Organization (BIO) is applauding efforts by the United States…
gooddaybio-cover-final
Daily News You Can’t Afford to Miss

Read it in under 3 minutes!

The Good Day BIO newsletter is the only daily newsletter at the intersection of biotech, politics, and policy.